Fundz
Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →

Pathos AI targets a $300M Series E financing round at a $3B valuation while announcing two licensing agreements worth up to $2.3B.

PRIVATEAug 04, 2026•3 days ago

Amount Raised

$300 Million

Round Type

Series E

ChicagoBiotechnology

Description

Pathos AI disclosed its goal of raising $300M in a Series E financing round, coinciding with two significant drug licensing agreements worth up to $2.3 billion. This move further cements the company's innovative approach to oncology trials using AI technology. The Series E financing aims to support the development of its AI platform, Foundry, focused on optimizing cancer drug trials. The announcements were made on August 3, 2026.

Company Information

Company

Pathos AI

Location

600 W. CHICAGO AVE.

Chicago, Illinois, United States

About

Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies. Pathos has raised over $100 million to accelerate the development of precision medicines and to expand its platform, combining computational approaches across multimodal real-world data and patient-derived biological models.

Related People

Suggested for you
1 contact
Verified contactsNo contacts on file at Pathos AI yet.
Predictive Intelligence
Strategic

ML-powered predictions for Pathos AI's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Pathos AI? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan